Metabolic Network Analysis Predicts Efficacy of FDA-approved Drugs Targeting the Causative Agent of a Neglected Tropical Disease

BMC Systems Biology - United Kingdom
doi 10.1186/1752-0509-6-27
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Quantitative Analysis on the Characteristics of Targets With FDA Approved Drugs

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2008English

Analysis of FDA Approved Anticancer Drugs Reveals the Future of Cancer Therapy

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2004English

Identification of FDA Approved Drugs Targeting COVID-19 Virus by Structure-Based Drug Repositioning

2020English

Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity

Scientific Reports
Multidisciplinary
2013English

Repurposing FDA-approved Drugs for Anti-Aging Therapies

Biogerontology
AgingGerontologyGeriatrics
2016English

Analysis of the Ultra-Orphan Drugs Approved by the Fda in the Period 1983-2014

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

A Review on the Drugs Approved by US-FDA and DCGI

TEXILA INTERNATIONAL JOURNAL OF CLINICAL RESEARCH
2016English

Targeting the Β-Clamp in Helicobacter Pylori With FDA-approved Drugs Reveals Micromolar Inhibition by Diflunisal

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2017English

Identification of FDA-approved Drugs That Computationally Bind to MDM2

Chemical Biology and Drug Design
BiochemistryOrganic ChemistryDrug DiscoveryMolecular MedicinePharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy